Login / Signup

Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction : A Post Hoc Analysis of the DAPA-HF Trial.

Jawad Haider ButtPooja DewanBela MerkelyJan BelohlávekJarosław DrożdżMasafumi KitakazeSilvio E InzucchiMikhail N KosiborodFelipe A MartinezSergey TereshchenkoPiotr PonikowskiOlof F BengtssonDaniel LindholmAnna Maria LangkildeMorten SchouMikaela SjöstrandScott D SolomonMarc S SabatineChern-En ChiangKieran F DochertyPardeep S JhundLars Valeur KøberJohn Joseph Valentine McMurray
Published in: Annals of internal medicine (2022)
AstraZeneca.
Keyphrases
  • heart failure
  • acute heart failure
  • phase iii
  • study protocol
  • phase ii
  • clinical trial
  • left ventricular
  • community dwelling
  • cardiac resynchronization therapy
  • randomized controlled trial
  • open label